Letters
- 1 May 2001
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 18 (5) , 423-424
- https://doi.org/10.1046/j.1464-5491.2001.00476-2.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?Diabetes, 2000
- Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathyKidney International, 2000
- Matrix Metalloproteinases in Renal Development and DiseaseJournal of the American Society of Nephrology, 2000
- A novel and simple immunocapture assay for determination of gelatinase-b (MMP-9) activities in biological fluids: Saliva from patients with Sjögren's Syndrome contain increased latent and active gelatinase-b levelsMatrix Biology, 1998
- Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitusAmerican Journal of Kidney Diseases, 1998
- Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromesJournal of the American College of Cardiology, 1998
- VEGF and diabetic microvascular complicationsNephrology Dialysis Transplantation, 1997
- Endothelial dysfunction and pathogenesis of diabetic angiopathyCardiovascular Research, 1997
- Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cellsJournal of Cellular Physiology, 1992
- The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic NephropathyDiabetes, 1983